Recent research found a correlation between the upfront time to build and release a clinical database and its impact on downstream data management processes in conducting and completing trials.

In the dynamic environment of biotechnology trials, the significance of Clinical Data Management systems (CDMs) cannot be overstated. As we navigate the complexities of these trials and the pivotal ...

Lakshmi Priya Darshini Pulavarthi is a skilled Clinical Data Management professional with over a decade of experience managing data from Phase I-III clinical trials. With a strong educational ...

The commercial success of existing lipid-lowering medications highlights the enormous market potential for effective ...

Scientists are closing in on the ability to apply genome editing to a formidable new target: the human brain. In the past two years, a spate of technological advances and promising results in mice ...

Millions of users of Meta Platforms‘ (NASDAQ:META) Facebook in the U.S. are set to receive their long-awaited compensation for a data privacy breach that occurred over a decade. The distribution of ...

A close-up of a pharmacist in a gleaming white labcoat holding a vial of biopharmaceuticals. Headquartered in California, Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is a clinical-stage ...

Our fifth annual Forbes Asia 100 to Watch list provides a window into the vibrant world of startups and small companies in ...

As mental health systems come under strain, some are turning to AI chatbots for support. But experts warn that machines can’t ...

Schools throughout Utah are grappling with how to properly use or restrict the use of artificial intelligence. Although ...